drugset / Trial / NCT01021358
A Study to Assess the Effect of Ketoconazole on the Metabolism of ABT-263 (Navitoclax).
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This is a single dose, open-label, single or multiple center study to determine the interaction of ketoconazole with ABT-263 in approximately 12 subjects with cancer.
Timeline
- Start
- 2010-01
- Primary completion
- 2010-10
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ketoconazole | Small molecule | — | — |
| Subject | Navitoclax | Small molecule | — | — |